| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |